terameprocol has been researched along with betadex in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blomberg, JA; Goodman, AB; Heller, J; Lopez, RA; Rhodes, M | 1 |
1 other study(ies) available for terameprocol and betadex
Article | Year |
---|---|
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Excipients; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Masoprocol; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Polyethylene Glycols; Survival Analysis | 2007 |